SEC Filing (10-K) - Annual Report
(WorldNews Europe)

10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File No. 000-53832 VITALITY BIOPHARMA, INC. (Exact name of registrant as specified in charter) Nevada 75-3268988 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 1901 Avenue of the Stars, 2nd Floor Los Angeles, California 90067 (530) 231-7800 (Address of...